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We have previously observed impairing effects of social defeat stress (CSDS) on inhibitory avoidance (IA) in mice. Given the similarity 
between changes produced by social stress in animals and symptoms of certain human psychopathologies such as depression and 
anxiety, the effects of the antidepressant clomipramine on IA impairment produced by CSDS were evaluated in the present study. 
Male CD1 mice were randomly assigned to the groups: non-stressed+saline, non-stressed+clomipramine, stressed+saline and 
stressed+clomipramine. Stressed animals were subjected to daily agonistic encounters (10 min) in the home cage of the aggressor over 
a 20-day period. Just before each encounter, non-stressed and stressed mice were injected i.p. with saline or clomipramine (10 mg/kg) 
according to their experimental condition. 24 hours after the last CSDS session, all the mice were tested in a step-through IA task. In the 
IA training phase, animals were punished by a shock to the paw when they entered the dark compartment of the apparatus. In the IA 
test phase (one week later) the same procedure took place, but without shock. Complementary measures were obtained by evaluating 
all the animals in an elevated plus maze (locomotor activity and emotionality) and on a hot plate (analgesia). IA learning was confirmed in 
all groups except the stressed+saline group, which was the only one that exhibited higher anxiety levels. No variations were observed in 
either locomotor activity or analgesia. In conclusion, CSDS induces anxiety and impairs emotional memory in mice; the negative effects 
of CSDS on memory appear to be attenuated by clomipramine, and these detrimental effects do not seem to be secondary to the effects 
of CSDS on locomotor activity, emotionality or pain sensitivity.
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INTRODUCTION
Social stressors are the main source of stress in humans 
and contribute to the development and expression of 
diverse pathologies, representing a major risk factor 
for depression (e.g. Campeau et al. 2011). In fact, 
heightened stress reactivity and dysregulation of the 
HPA (hypothalamus-pituitary-adrenal) axis are some of 
the most consistent features in patients suffering from 
major depression (Holsboer 2000, Gallagher et al. 2007, 
Holsboer and Ising 2010), while remission of this pathology 
is associated with normalization of the HPA axis (Holsboer 
2000, Ising et al. 2007). Experimental studies that address 
the long-term effects of social stress, due to ethical and 
time constraints, often require the use of animal models 
(Tanaś et al. 2015). Social defeat stress in animals, defined 
as being defeated in confrontations with conspecific 
animals (Jin et al. 2015), is frequently induced by the 
resident/intruder paradigm (Björkqvist 2001). This kind of 
stress has been reported to cause a variety of behavioral, 
neuroendocrinological, physiological, neurochemical, 
neurological and immunological changes (Blanchard et 
al. 2001, Buwalda et al. 2005, Niebylski et al. 2012) that 
resemble certain symptoms of human psychopathologies, 
such as depression and anxiety (Bartolomucci and Leopardi 
2009). Therefore, animal models based on social stress are 
becoming increasingly popular for studying the relation 
between stress and the aforementioned psychopathologies 
(Sgoifo and Meerlo 2002, Wood et al. 2010). CSDS (chronic 
social defeat stress) is an animal model widely used 
nowadays to emulate human diseases related to stress, 
such as anxiety (e.g. Watt et al. 2009, Toth and Neumann 
2013) and depression (e.g. Venzala, et al. 2012, Iñiguez et al. 
2014), in order to determine the underlying mechanisms 
and identify potential pharmacological treatments.
Memory impairment can be also an important negative 
consequence produced by stress (e.g. Trofimiuk et al. 2006), 
and has previously been shown to be induced by CSDS 
in several animal paradigms (Ohl and Fuchs 1998, 1999, 
Touyarot et al. 2004, Wang et al. 2011, Patki et al. 2013, © 2
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Monleón et al. 2015, 2016). For example, Ohl and Fuchs (1998, 
1999) observed memory deficit in a modified hole-board 
task in male tree shrews exposed to CSDS. Touyarot and 
others (2004) reported a deficit in spatial learning in the 
Morris water maze in highly-reactive-to-novelty rats 
undergoing a 21-day CSDS schedule. Wang and colleagues 
(2011) also reported impairments in the spatial memory of 
chronically stressed mice (21 daily encounters of CSDS) in 
novel object recognition and the Y-maze, while Patki and 
others (2013) observed worse long-term memory in socially 
defeated rats tested in a radial arm water maze task. 
Inhibitory avoidance (IA), or passive avoidance, is a 
common procedure used to evaluate memory in animals 
(Gold 1986), which mainly involves emotional memory. 
In the step-through version, which was employed in the 
present and previous studies carried out in our laboratory 
(e.g. Parra et al. 2000, 2010, 2013, Monleón et al. 2002, 2009, 
2015, 2016, Everss et al. 2005, Arenas et al. 2006), the animal 
is punished by a shock to the paw when it enters the dark 
compartment, which leads to an inhibition of its behavioral 
response in order to evade receiving a future shock (Bureš et 
al. 1983). In previous studies using the CD1 strain as stressed 
subjects, in place of the C57BL/6J strain used in the standard 
protocol (Golden et al. 2011), we found that CSDS (a 3-week 
period of 10-min daily sessions) prevented the formation 
of IA memory in post-pubertal mice. Furthermore, these 
effects of CSDS on memory were not secondary to motor or 
emotional effects of stress (Monleón et al. 2015, 2016). 
As previously mentioned, stress has long been linked 
to neuropsychiatric diseases, such as depression (Barden 
2004). Memory impairment is also a symptom of depression 
(e.g. Ramponi et al. 2010), and, along with other symptoms, 
is reduced by antidepressant therapy (Antikainen et al. 
2001). Thus, the aim of the present work was to investigate 
whether chronic antidepressant treatment reverses 
the memory impairment produced by CSDS. In rodents 
repeatedly exposed to social defeat, there is a decrease in 
volume and cell proliferation in the hippocampus that can 
be reversed by chronic antidepressant treatment (Czéh 
et al. 2007, Becker et al. 2008, Van Bokhoven et al. 2011). 
Clomipramine, a tricyclic antidepressant widely used to 
treat depression and obsessive compulsive disorder, has 
been shown to reverse the behavioral deficits and inhibition 
of cell proliferation in the adult hippocampus induced by 
chronic unpredictable stress (Liu et al. 2008, 2012).
We have evaluated the effect of chronic clomipramine 
on IA impairment produced by CSDS in post-pubertal male 
CD1 mice, hypothesizing that clomipramine would reverse 
the negative effects of CSDS on memory. In addition to the 
IA task, our animals were assessed in an elevated plus maze 
and a hot plate in order to obtain complementary measures 
of locomotor activity, emotionality and analgesia, as they 
could be confounding factors in the animals’ performance 
of the main task.
METHODS
Subjects
Post-pubertal (42 days) male CD1 mice (Charles River, 
Lyon, France) were used as experimental subjects. The 
animals arrived at the laboratory weighing 30–43 g and 
were housed in groups of 4 or 5 in translucent plastic 
cages (height 14.5 cm, width 27 cm, length 27 cm) with 
roofs of stainless steel bars (Panlab S.L., Barcelona, Spain). 
Male CD1 retired breeder mice of over 3 months of age 
(Janvier, France) were housed individually in similar 
cages in preparation for their use as aggressors. All the 
animals were maintained in a temperature-controlled 
room (21±2°C) under a reversed light-dark cycle (lights 
off: 7:30 a.m.–7:30 p.m., local time) with food and water 
available ad libitum. Group-housed mice were marked for 
recognition by painting their fur with purple coloring. 
The animals were subjected to a stress treatment and to 
several behavioral tests during the dark phase of the cycle. 
Adequate measures were taken to minimize any pain or 
discomfort caused to the animals and they were evaluated 
daily by veterinary personnel. The experimental protocol 
and use of animals were in compliance with the European 
Community’s Council Directive of 22 September 2010 
(2010/63/EU) and the Spanish Real Decreto 53/2013.
Drugs
Clomipramine hydrochloride (Sigma-Aldrich Química, 
S.A., Madrid, Spain) was dissolved in physiological saline 
(0.9% NaCl) and administered i.p. in a volume of 0.01ml/g 
body weight. The control groups received the same volume 
of physiological saline.
Behavioral paradigms and apparatus
A step-through inhibitory avoidance apparatus for 
mice (Ugo Basile, Comerio-Varese, Italy), contained within 
an isolation box, was employed to evaluate memory. This 
cage is made of Perspex sheets and is divided into two 
compartments (both with a height of 15 cm, width of 
9.5 cm, and length of 16.5 cm) separated by a partition 
with an automatically-operated sliding door. The floor is 
made of 48 stainless steel bars with a diameter of 0.7 mm 
and situated 8 mm apart. The safe compartment is white 
and continuously illuminated by a light fixture fastened to 
the cage lid (24 V, 10 W, light intensity of 290 lux at floor 
level, measured with the Panlux Electronic2 photometer 
manufactured by GOSSEN, Nürnberg, Germany), whereas 
the “shock” compartment is made of black Perspex panels 
and is maintained in darkness at all times. 
7_815_Duque_v3.indd   226 08/09/16   21:23
Acta Neurobiol Exp 2016, 76: 225–233 Social stress, clomipramine and memory 227
An elevated plus maze for mice (Cibertec, Madrid, 
Spain) was applied to measure unconditioned anxiety-like 
behavior and locomotor activity. This apparatus consists 
of two open arms (30×5 cm2 each) and two enclosed arms 
with walls (30×5×15 cm3 each) that extend outwards from 
a common central square (5×5 cm2). The maze is made of 
Plexiglas (black floor and walls) and is elevated to a height 
of 40 cm above floor level.
To assess nociceptive perception, we employed a hot 
plate (Mod. Socrel DS37, Ugo Basile, Varese, Italy) consisting 
of a metal plate (25×25 cm2) located above a thermoregulator 
and a plastic cylinder (height 18 cm and diameter 19 cm) 
made of Plexiglas.
Procedure
After 10 days of acclimatization to the animal 
facility, mice were randomly distributed into four 
groups (n=12–14): NS+SAL (non-stressed+saline), NS+CLO 
(non-stressed+clomipramine), S+SAL (stressed+saline) and 
S+CLO (stressed+clomipramine). 
Following a modified version of the guidelines proposed 
by Golden and colleagues (2011), a Chronic Social Defeat 
Stress (CSDS) paradigm was used as an animal model of 
social stress. In this paradigm, experimental male mice 
(stressed animals) are repeatedly subjected to bouts of 
social defeat by a larger CD1 mouse that has screened 
positive for aggressive behavior. In a pre-stress phase, 
CD1 retired breeders were selected as aggressors based 
on their attack latencies and the number of attacks they 
had launched during a 3-day screening procedure (attack 
latencies shorter than 60 s and 3 or more attacks in 3 min 
were the aggressor inclusion criteria). A total number of 
28 aggressors were finally selected in this pre-stress phase. 
In the CSDS phase, the stressed groups were submitted 
to a daily 10-min social defeat experience by a larger and 
aggressive mouse on 20 consecutive days. In the agonistic 
encounters, each stressed mouse (also called the intruder) 
was placed in the home cage of an unfamiliar male (the 
aggressor, also called the resident). All the residents rapidly 
recognized and launched a first attack against the intruder 
within the 2 first minutes. Once the experimental mouse had 
been physically stressed by defeat during a 10-min period, 
both animals (intruder and resident) were maintained 
in sensory contact for 1 h by means of a clear perforated 
Plexiglas divider that divided the resident home cage into 
two halves. Subsequently, the intruder was returned to its 
home cage. In each subsequent defeat, experimental mice 
were exposed to a novel resident mouse. Just before each 
agonistic encounter, all stressed animals were injected daily 
i.p. with saline or clomipramine (10 mg/kg) according to 
their experimental condition. Non-stressed mice (NS+SAL 
and NS+CLO groups) were not submitted to any social 
exposure, and the only manipulation they underwent was 
the daily pharmacological treatment. The body weight 
of all animals was monitored before and after the CSDS 
procedure. Taking into account that social defeat involves 
physical aggression and wounding, defeated mice were 
evaluated daily by veterinary personnel. All the encounters 
were supervised by a blind experimenter and none needed 
to be terminated due to excessive aggression. Nevertheless, 
after successive encounters, and in accordance with 
criteria of the veterinary personnel in our laboratory, 
two intruders were removed from the experiment and 
immediately euthanized because of excessive wounding, as 
indicated in the protocol of Golden and others (2011).
Twenty-four hours after the last CSDS session, 
all mice were submitted to a one-trial step-through 
inhibitory avoidance task, which was the main behavioral 
test employed in the study. This task consisted of two 
phases: training and test. The training phase began with 
a 90-s adaptation period in the light compartment of 
the apparatus. Following this, the door between the 
compartments was opened and the time taken to enter the 
dark compartment – defined as latency – was automatically 
measured in tenths of a second and manually recorded. The 
mouse was allowed to remain in the light compartment for 
a maximum of 300 s after the door had opened. As soon as 
the animal entered the dark compartment, the sliding door 
was closed and a foot-shock (0.3 mA for 5 s) was delivered 
through the grid floor. The test phase took place one week 
later, following the same procedure as in the training 
phase, with the exception that no shock was delivered.
Twenty-four hours after the test phase of the inhibitory 
avoidance task, control and stressed mice were evaluated 
in an elevated plus maze in a complementary behavioral 
test, as in previous studies carried out in our laboratory 
(e.g. Vinader-Caerols et al. 2006, Monleón et al. 2015, 
2016). This task consisted of a 5-min session that began 
by placing the mouse in the central square (facing one of 
the open arms). All sessions were recorded with a video 
camera (Sony DCR-SR35) for subsequent analysis. The 
number of entries into the open and closed arms (entry is 
defined as all four paws being placed on an arm) was scored 
by a trained observer who was unaware of the treatment 
applied. Based on former studies (Lister 1987, Rodgers and 
Johnson 1995, Rodgers and Dalvi 1997, File 2001, Campos 
et al. 2013, Sestakova et al. 2013), these scores provide 
an uncontaminated measurement of locomotor activity 
through the number of closed arm entries, and one primary 
anxiety index through the percentage of open arm entries 
(the lower the score, the higher the anxiety).
Twenty-four hours after the elevated plus maze test, all 
mice were evaluated on a hot plate as a second complementary 
behavioral test. The metal plate was heated through a 
thermoregulator to a fixed temperature of 55°C (the surface 
temperature was continuously monitored). Each mouse was 
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placed on the hot plate inside a plastic cylinder to confine 
it to the heated surface. The latency to the lifting of one or 
both hind paws was recorded in seconds (s) and provided 
a nociceptive measurement (the lower the score, the higher 
the nociception). The animals that failed to lift their paws 
within 45 s were removed from the plate (to avoid thermal 
injury) and were assigned a response latency value of 45 s.
Statistical analyses
Inhibitory avoidance data were transformed into 
proportion (p=x/300) values and then to arc sin (arc sin 
√p) values according to Snedecor and Cochran (1980). 
This transformation is appropriate when a cut-off time is 
applied, and crossing latencies that exceed this limit are 
interpreted as the maximum trial length. Therefore, all 
latencies are transformed into a percentage or proportion 
values, and these percentages (p) are then transformed to 
arc sin (degree) values (according to the formula: arc sin 
√p) prior to statistical analysis and graphical constructions. 
A repeated measures analysis of variance (rANOVA) was 
then performed, with “Stress” (non-stressed and stressed) 
and “Drug” (saline and clomipramine) as between-subjects 
factors and “Phase” (training and test) as a within-subject 
factor (the repeated-measure factor). Two-way ANOVAs for 
training and test phases were also performed separately. 
Training and test sessions were compared within the same 
group using the Student’s t test for dependent samples. 
After checking that data fulfilled the criteria for 
normality and homogeneity, two-way ANOVAs were 
also carried out for the anxiety, locomotor activity and 
nociception data obtained in the elevated plus-maze and 
hot plate tests. The p value for statistical significance was 
set at p<0.05.
All analyses were performed using the “SPSS” software 
package, version 22 for windows by IBM Corp (2010).
RESULTS
Inhibitory avoidance
The rANOVA revealed that the main factor Phase was 
statistically significant (F1,47=53.25, P<0.001), with test latencies 
being longer than training latencies. The main factor Stress 
(F1,47=12.11, P<0.001) was also statistically significant, with 
stressed animals showing significantly lower escape latencies 
than non-stressed subjects. The interaction Phase X Stress 
was statistically significant (F1,47=16.53, P<0.001), showing 
that there were differences in escape latencies between 
non-stressed and stressed mice in the test phase but not in 
the training phase (see Fig. 1). Neither the main factor Drug 
(F1,47=0.43, n.s.) nor any interaction involving this factor was 
statistically significant (Phase X Drug: F1,47=0.52, n.s.; Stress X 
Drug: F1,47=0.03, n.s.; Phase X Stress X Drug: F1,47=0.06, n.s.).
Training
The two-way ANOVA for the training phase showed that 
the factors Stress and Drug were not statistically significant 
(F1,47=0.04, n.s.; F1,47=0.01, n.s.; respectively), and neither was 
the interaction Stress X Drug (F1,47=0.51, n.s.).
Test
The two-way ANOVA for the test phase revealed that the 
main factor Stress was statistically significant (F1,47=18.62, 
P<0.001), with stressed animals showing significantly 
Fig. 1. Effects of CSDS on training and test latencies of post-pubertal male 
CD1 mice in an inhibitory avoidance task (non-stressed group: n=26; 
stressed group: n=25). Values are expressed as means (+SEM) of square 
root of proportions (p=x/300) transformed to arc sin. ***p<0.001 vs. 
TRAINING; ###p<0.001 vs. NON-STRESSED.
Fig. 2. Effects of CSDS and clomipramine on training and test latencies of 
post-pubertal male CD1 mice in an inhibitory avoidance task. NS+SAL=non-
-stressed+saline group (n=12); NS+CLO=non-stressed+clomipramine group 
(n=14); S+SAL=stressed+saline group (n=13); S+CLO=stressed+clomipramine 
group (n=12). Values are expressed as means (+SEM) of square root of 
proportions (p=x/300) transformed to arc sin. *p<0.05, ***p<0.001 vs. 
TRAINING.
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lower test latencies than non-stressed subjects (see Fig. 1). 
Neither the factor Drug nor the interaction Stress X Drug 
was statistically significant (F1,47=0.39, n.s.; F1,47=0.01, n.s.; 
respectively).
Training vs. test
Inhibitory avoidance learning (significantly longer test 
latencies than training latencies) was observed in NS+SAL 
(P<0.0001), NS+CLO (P<0.0001) and S+CLO (P<0.05). However, 
inhibitory avoidance was absent in the S+SAL group (P>0.05) 
(see Fig. 2).
Elevated Plus Maze
Locomotor activity (number of entries in enclosed arms)
Stress and Drug were not statistically significant 
(F1,47=1.02, n.s.; F1,47=2.75, n.s.; respectively), and neither was 
the interaction Stress X Drug (F1,47=0.05, n.s.) (see Fig. 3). 
Anxiety (percentage of open arm entries)
The two-way ANOVA showed significant differences in 
the measurement of anxiety, with the main factor – stress 
– proving to be statistically significant (F1,47=7.3, P<0.05) and 
significantly higher anxiety (lower scores) being detected 
in stressed vs. non-stressed subjects (see Fig. 4). Neither 
the factor Drug nor the interaction Stress X Drug was 
statistically significant (F1,47=0.25, n.s.; and F1,47=2.41, n.s.; 
respectively).
Hot plate
No statistically significant differences were observed 
for either of the main factors – Stress or Drug (F1,47=0.14, 
n.s.; F1,47=0.01, n.s.; respectively) – or their interaction 
(F1,47=0.41, n.s.) (see Fig. 5). 
DISCUSSION
The aim of the present study was to investigate the 
effects of the tricyclic antidepressant clomipramine on IA 
impairment produced by CSDS in post-pubertal male CD1 
mice. Overall, stressed subjects performed the IA task more 
poorly than non-stressed animals, regardless of whether 
they received saline or clomipramine treatment; and all 
the groups, with the exception of the non-drugged stressed 
animals (S+SAL group), showed IA learning.
In accordance with reports of the behavioral deficits, 
especially on memory, produced by CSDS in other paradigms 
(Ohl and Fuchs 1998, 1999, Touyarot et al. 2004, Wang et 
al. 2011, Patki et al. 2013), we have observed that CSDS 
impaired IA conditioning in post-pubertal mice: stressed 
subjects exhibited lower test latencies than non-stressed 
animals, which means that being submitted to CSDS had 
detrimental effects on their memory. Moreover, only 
Fig. 3. Effects of CSDS and clomipramine on locomotor activity (number 
of closed arm entries) in post-pubertal male CD1 mice in an elevated plus 
maze task (n=12–14 per group). Values are expressed as means (+SEM). 
Fig. 4. Effects of CSDS and clomipramine on anxiety (percentage of open 
arm entries) in post-pubertal male CD1 mice in an elevated plus maze task 
(n=12–14 per group). Values are expressed as means (+SEM). #p<0.05 vs. 
control (NON-STRESSED groups).
Fig. 5. Effects of CSDS and clomipramine on latencies to lift hind paws 
in post-pubertal male CD1 mice in a hot plate task (n=12–14 per group). 
Values are expressed as means (+SEM).
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non-drugged stressed animals failed to exhibit IA learning, 
unlike animals in the other groups, in which IA conditioning 
was confirmed. In relation to the memory processes most 
affected by CSDS, and taking into account that social stress 
was implemented before the memory task, we suspect that 
CSDS impaired mainly the memory acquisition process. 
Consolidation and retrieval memory processes were 
somehow less or not affected by CSDS, as social stress was 
no longer present (i.e. no agonistic encounters took place 
between training and test phases of the memory task). In 
this way, it could be said that CSDS impaired the learning 
rather than the memory of this task. The present results 
are also consistent with previous findings in our laboratory 
using the same degree of CSDS and the same behavioral 
task (but without pharmacological treatment), in which 
CSDS produced impairing effects on IA (Monleón et al. 
2015, 2016). Several explanations in the neurobiology of 
these effects have been proposed, such as neuritic atrophy, 
reduced neurogenesis and decreased neurotrophin levels 
in the hippocampus, as well as changes in the levels of 
brain-derived neurotrophic factor within the basolateral 
amygdala (Krishnan 2014). Actually, this structure is 
activated during emotional experiences that the individual 
perceives as anxiety, fear, stress and rage (Rogan and 
LeDoux 1996). The amygdala, an important brain region 
involved in the control of affective stimuli (Lehner et al. 
2010), including those related to the emotional memory of 
IA, is possibly also the most important structure affected 
by the effects of CSDS on IA learning. It is well known that 
some emotional experiences mediated by the activation 
of amygdala are better remembered (e.g. McGaugh 2002, 
2004, Wolf 2008). Nevertheless, it is also possible that this 
activation by CSDS is focused on fear-inhibiting pathways 
(Ehrlich et al. 2009), which prevented IA learning in the 
S+SAL group in our study. 
The antidepressant clomipramine has been widely 
used to treat psychiatric disorders. Besides its use in 
depression, it is a reference treatment for anxiety disorders 
such as obsessive-compulsive disorder and panic disorder 
(Calegari et al. 2007). Unlike non-drugged stressed animals 
(S+SAL group), our stressed mice receiving clomipramine 
(S+CLO group) learned the IA task, which proves that 
chronic clomipramine treatment is effective in reversing 
the memory impairment produced by CSDS. 
There are reports in the literature that pre-training 
administration of acute high doses (40 mg/kg) of 
clomipramine have detrimental effects on IA learning 
in mice, whilst chronic administration of lower doses 
(15 mg/kg) improves this kind of learning in rats (see 
Monleón et al. 2008). In the present study, chronic 
administration of clomipramine (10 mg/kg) did not have 
a significant effect when administered to non-stressed 
animals, but it counteracted the adverse effects of CSDS on 
memory when administered to defeated animals. It has also 
been repeatedly observed that infusions of norepinephrine 
into the amygdala enhance memory consolidation of a 
wide variety of training experiences (e.g. Hermans et 
al. 2014). Taking into account that the amygdala is one 
of the main brain structures involved in the IA task, and 
that clomipramine, though more selective for serotonin 
reuptake inhibition, is involved in norepinephrine reuptake 
inhibition, it is reasonable to think that this drug is capable 
of reversing the negative effects produced by CSDS in the IA 
task. Indeed, given that stress is thought to induce a broad 
spectrum of behavioral changes considered as important 
analogues of depressive symptoms in both humans (e.g. 
Lavergne and Jay 2010) and animals (e.g. Gardier 2009, Lee 
and Kim 2010), it is not surprising that the antidepressant 
clomipramine counteracts memory impairment produced 
by CSDS.
Spontaneous locomotor activity in our stressed mice 
was not affected by CSDS. Several studies have found that 
defeated animals commonly show a decrease in motor 
activity, with this hypo-activity being reported in several 
species, including rats (e.g. Watt et al. 2009), tree shrews 
(e.g. Van Kampen et al. 2000) and mice (e.g. Iñiguez et 
al. 2014). In contrast, other studies have reported no 
significant decrease in activity (Monleón et al. 2015, 2016) 
or hyperactivity (Venzala et al. 2013). The lack of motor 
effects observed in the present study was evident not only 
in the elevated plus-maze task (in which no differences 
were observed in the number of entries into the closed 
arms), but also in the IA task, as no statistically significant 
differences were observed between stressed and control 
mice in terms of their training latencies. Therefore, it can 
be concluded that the effects of CSDS on memory are not 
secondary to the motor effects of stress.
In the present study, CSDS led to changes in the anxiety 
measure between stressed and non-stressed animals, with 
socially defeated mice showing anxiety-like behavior (i.e., 
lower percentage of open arm entries). Some studies have 
found that social stress enhances anxiety-like behaviors of 
rats (Haller and Halasz 2000) and mice (Bahi 2013, Monleón 
et al. 2015, 2016) in the elevated plus-maze test, although 
others have failed to detect such an enhancement (Martinez 
et al. 1998). Anxiety could act as a confounding factor in the 
effects of CSDS on memory, which means that the higher level 
of anxiety/fear of stressed animals observed in the present 
study would have resulted in these subjects taking longer 
to enter the dangerous compartment; as a consequence, 
their IA performance would have improved. However, our 
stressed mice did not display IA learning. Thus, the effects 
of CSDS on memory would appear not to be secondary to its 
effects on anxiety, as occurs in the case of its motor effects. 
We observed no effects of chronic clomipramine treatment 
in either stressed or non-stressed animals in the elevated 
plus maze in the present study. It has been reported that 
the effects of clomipramine on heart rate, a physiological 
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anxiety measure, depend on the dose administrated (Frank 
et al. 2006). Therefore, it is reasonable to suspect that the 
lack of effects of clomipramine in reducing the anxiety 
symptoms of our stressed subjects was due to the dose of 
clomipramine administered. 
It is important to confirm that CSDS does not increase 
animals’ innate fear of light environments, as this could 
also act as a confounding factor in the effects of social 
stress on IA performance (an increased fear of light would 
lead to shorter escape latencies). This can be checked by 
a Light/Dark transition test (without shock). Although such 
a Light/Dark test was not included in the present study, 
it can be argued that, if CSDS had increased the animals’ 
innate fear of light, stressed subjects would have displayed 
shorter latencies than non-stressed mice in the training 
phase of the IA task (not only in the test phase). However, no 
significant differences in training latencies were observed 
between groups. Therefore, we believe that this potential 
confounding factor can be ruled out from our study. 
A reduced pain perception is a classic effect produced by 
a variety of acute stressors in humans and animal models 
(Miguez et al. 2014). However, stress is reported to inhibit or 
exacerbate pain perception depending on the nature and/or 
parameters of the stressor (Butler and Finn 2009). This dual 
action of stress on pain modulation depends to a great extent 
on pre-existing conditions, in particular previous pain 
experience associated with methodological factors, along 
with previous adverse life events (Larauche et al. 2012). In 
our study, pain sensitivity in chronically defeated mice 
was indistinguishable from that in non-defeated controls. 
Therefore, similarly to the rationale applied to motor and 
emotional effects, we consider that the effects of CSDS on 
memory are not secondary to its effects on pain sensitivity.
As with any research, our study has limitations and 
strengths. From our point of view, the main limitation 
of the present experiment is the use of a single dose of 
clomipramine, as testing a wider range of doses would 
have been ideal. We selected a single dose of clomipramine 
due to limitations in our laboratory in terms of the 
facilities and resources necessary for submitting such a 
number of animals to CSDS in an experimental design 
administrating several doses of drug. The specific dose of 
clomipramine we have employed was based on previous 
studies in which pre-training administration of a rather 
low dose of clomipramine improved IA, whilst high 
doses had detrimental effects, as mentioned above. With 
respect to the strengths, the present work represents a 
step forward in the study of pharmacological treatment 
of the effects of CSDS on memory. Our results show that 
treatment with clomipramine is effective in attenuating 
CSDS-induced memory impairment. Importantly, we 
have controlled several potential confounding factors 
(locomotor activity, emotionality and pain sensitivity) 
through complementary tasks. 
CONCLUSIONS
The present study shows that: (i) CSDS impairs 
emotional memory involved in inhibitory avoidance in 
post-pubertal mice; (ii) the memory impairment produced 
by CSDS is slightly attenuated by a low dose (10 mg/kg) 
of the tricyclic antidepressant clomipramine; (iii) the 
detrimental effects of CSDS on emotional memory do not 
seem to be secondary to the effects of stress on locomotor 
activity, emotionality or pain sensitivity; and (iv) this work 
provides further evidence that CD1 is a valid strain of mice 
for use as stressed subjects in the CSDS protocol.
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